Radical cystectomy in people with spinal cord injury (SCI) provides numerous additional difficulties, compared to able-bodied people. Therefore, it is important to obtain information from an experienced team about optimally managing these patients.
Surgical procedures, based on the experience of 12 radical cystectomies in SCI patients with bladder cancer between January 1st, 2001, and December 31st, 2020, were recorded and the operative and perioperative clinical data were evaluated. Surgery was performed in a high-volume center by the surgeon most experienced in radical cystectomies, assisted by the neuro-urologist, involved in the care of the patient from the spinal cord center. Furthermore, a checklist based on the experience of the surgeon and the assisting neuro-urologist was developed.
SCI patients mostly suffered from an advanced disease and were always operated by the same team. The hospital stays ranged from 23 to 134 days (median 42 days). Four of the patients suffered from a postoperative paralytic ileus. Otherwise, both the operation time and the intraoperative blood loss as well as intraoperative and postoperative complications were basically comparable with those in able-bodied patients. The special features of radical cystectomy in SCI bladder cancer patients are described. Furthermore, a checklist addressing preoperative red flags, intra-operative challenges and post-operative challenges is presented.
Radical cystectomy in SCI patients should be performed in a high-volume department by the most experienced surgical team. The inclusion of the urologist caring for the patient from the spinal cord injury center is highly recommended.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:56–87
Savic G, DeVivo MJ, Frankel HL, Jamous MA, Soni BM, Charlifue S (2017) Causes of death after traumatic spinal cord injury—a 70-year British study. Spinal Cord 55:891–897
National Spinal Cord Injury Statistical Center, University of Alabama at Birmingham (2018) Annual statistical report—complete public version. https://www.sci-info-pages.com/wp-content/media/NSCISC-2018-Annual-Report.pdf. Accessed 09 Oct 2021
Böthig R, Kowald B, Fiebag K, Balzer O, Tiburtius C, Thietje R, Kadhum T, German-speaking Medical SCI Society (DMGP) Bladder Cancer Extended Working Group, Golka K (2021) Bladder management, severity of injury and period of latency: a descriptive study on 135 patients with spinal cord injury and bladder cancer. Spinal Cord 59:971–977
Böthig R, Tiburtius C, Fiebag K, Kowald B, Hirschfeld S, Thietje R, Kurze I, Schöps W, Böhme H, Kaufmann A, Zellner M, Kadhum T, Golka K (2020) Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database. World J Urol 38:2827–2834
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Böthig R, Tiburtius C, Schöps W, Zellner M, Balzer O, Kowald B, Hirschfeld S, Thietje R, Pietsch A, Kurze I, Forchert M, Kadhum T, Golka K (2021) Urinary bladder cancer as a late sequela of traumatic spinal cord injury. Mil Med Res 8:29
Stein JP, Skinner DG (2004) Surgical atlas. Radical cystectomy. BJU Int 94:197–221
Phé V, Karsenty G (2020) Urinary diversion. In: Corcos J, Karsenty G, Kessler T, Ginsberg D (eds) Essentials of the adult neurogenic bladder, 1st edn. CRC Press, Boca Raton. https://doi.org/10.1201/9780429320675
Liu N, Zhou M, Biering-Sørensen F, Krassioukov AV (2015) Iatrogenic urological triggers of autonomic dysreflexia: a systematic review. Spinal Cord 53:500–509
Gui-Zhong L, Li-Bo M (2017) Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord 55:341–345
Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, Phé V (2018) Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn 37:1386–1395
Sampogna G, Maltagliati M, Galfano A, Bocciardi A, Rocco B, Micali S, Montanari E, Spinelli M (2020) Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder. Spinal Cord Ser Cases 6(1):61
Gerullis H, Ecke TH, Wishahi M, Georgas E, Eimer C, Otto T (2010) What happens if nothing happens? History of an untreated urothelial carcinoma of the bladder. J Egypt Soc Parasitol 40:789–796
Guillotreau J, Gamé X, Castel-Lacanal E, Mallet R, De Boissezon X, Malavaud B, Marque P, Rischmann P (2007) Laparoscopic cystectomy and transileal ureterostomy for neurogenic vesicosphincteric disorders. Evaluation of morbidity. Prog Urol 17:208–212 (French)
Guillot-Tantay C, Chartier-Kastler E, Perrouin-Verbe MA, Denys P, Léon P, Phé V (2018) Complications of non-continent cutaneous urinary diversion in adults with spinal cord injury: a retrospective study. Spinal Cord 56:856–862
Cheng JN, Lawrentschuk N, Gyomber D, Rogerson J, Bolton DM (2010) Cystectomy in patients with spinal cord injury: indications and long-term outcomes. J Urol 184:92–98
Roghmann F, Trinh QD, Braun K, von Bodman C, Brock M, Noldus J, Palisaar J (2014) Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol 21:143–149
Furrer MA, Huesler J, Fellmann A, Burkhard FC, Thalmann GN, Wuethrich PY (2019) The Comprehensive Complication Index CCI: a proposed modification to optimize short-term complication reporting after cystectomy and urinary diversion. Urol Oncol 37:291.e9-291.e18
Novara G, De Marco V, Aragona M, Boscolo-Berto R, Cavalleri S, Artibani W, Ficarra V (2009) Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 182:914–921
Vetterlein MW, Klemm J, Gild P, Bradtke M, Soave A, Dahlem R, Fisch M, Rink M (2020) Improving estimates of perioperative morbidity after radical cystectomy using the European Association of Urology quality criteria for standardized reporting and introducing the comprehensive complication index. Eur Urol 77:55–65
Cohn JA, Large MC, Richards KA, Steinberg GD, Bales GT (2014) Cystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes. Int J Urol 21:382–386
Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Ye D, Agerbaek M, Enting D, McDermott R, Gajate P, Peer A, Milowsky MI, Nosov A, Neif AJ Jr, Tupikowski K, Toms L, Fischer BS, Qureshi A, Collette S, Unsal-Kacmaz K, Broughton E, Zardavas D, Koon HB, Galsky MD (2021) Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma. N Engl J Med 384:2102–2114
Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucianò R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Farè E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS, Chung JH, Salvioni R, Mariani L, Montorsi F (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol 36:3353–3360
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer 2021. https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/. Accessed 28 Dec 2021
Necchi A, Raggi D, Gallina A, Madison R, Colecchia M, Lucianò R, Montironi R, Giannatempo P, Farè E, Pederzoli F, Bandini M, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Dehò F, Ali SM, Chung JH, Ross JS, Salonia A, Briganti A, Montorsi F (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77:439–446
Shsm H, Fahmy UA, Alhakamy NA, Khairul-Asri MG, Fahmy O (2021) Neoadjuvant therapy using checkpoint inhibitors before radical cystectomy for muscle invasive bladder cancer: a systematic review. J Pers Med 11:1195
Pottegård A, Kristensen KB, Friis S, Hallas J, Jensen JB, Nørgaard M (2020) Urinary tract infections and risk of squamous cell carcinoma bladder cancer: a Danish nationwide case-control study. Int J Cancer 146:1930–1936
Gordetsky JB, Montgomery KW, Giannico GA, Rais-Bahrami S, Thapa P, Boorjian S, Frank I, Cheville J (2022) The significance of squamous histology on clinical outcomes and PD-L1 expression in bladder cancer. Int J Surg Pathol 30:6–14
Böthig R, Balzer O, Tiburtius C, Fiebag K, Kowald B, Thietje R, Zellner M, Schöps W, Kadhum T, Golka K (2021) Denervation of the urinary bladder in spinal cord injury patients as an independent bladder cancer risk factor. Toxicol Lett 350:S152–S153
Guillotreau J, Panicker JN, Castel-Lacanal E, Viala F, Roumiguié M, Malavaud B, Marque P, Clanet M, Rischmann P, Gamé X (2012) Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis. Urology 80:852–857
Marrie RA, Maxwell C, Mahar A, Ekuma O, McClintock C, Seitz D, Webber C, Groome PA (2021) Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology 96(4):e501–e512
Böthig R, Schöps W, Kadhum T, Golka K (2021) Reader response: cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. In: Disputes and debates: rapid online correspondence. https://n.neurology.org/content/reader-response-cancer-incidence-and-mortality-rates-multiple-sclerosis-matched-cohort-study. Accessed 23 Jan 2022
Marrie RA, Maxwell C, Groome P Author response: Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. In: Disputes & debates: rapid online correspondence
Manach Q, Cussenot O, Rouprêt M, Gamé X, Chartier-Kastler E, Reus C, Camparo P, Compérat E, Phé V (2018) Analysis of bladder cancer subtypes in neurogenic bladder tumors. Can J Urol 25:9161–9177
Guillotreau J, Castel-Lacanal E, Roumiguié M, Bordier B, Doumerc N, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X (2011) Prospective study of the impact on quality of life of cystectomy with ileal conduit urinary diversion for neurogenic bladder dysfunction. Neurourol Urodyn 30:1503–1506
Mazouin C, Hubert J, Tricard T, Lecoanet P, Haudebert C, Bentellis I, Baron P, Hascoet J, Castes C, Verhoest G, Tibi B, Pradere B, Bruyere F, Capon G, Manunta A, Saussine C, Peyronnet B (2021) Robot-assisted cystectomy and ileal conduit for neurogenic bladder: comparison of extracorporeal vs intracorporeal urinary diversion. J Endourol 35:1350–1356
Haudebert C, Hascoet J, Freton L, Khene ZE, Dosin G, Voiry C, Samson E, Richard C, Neau AC, Drouet A, Mathieu R, Bensalah K, Verhoest G, Manunta A, Peyronnet B (2021) Cystectomy and ileal conduit for neurogenic bladder: comparison of the open, laparoscopic and robotic approaches. Neurourol Urodyn. https://doi.org/10.1002/nau.24855 (Epub ahead of print)
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Böthig, R., Rosenbaum, C., Böhme, H. et al. Special surgical aspects of radical cystectomy in spinal cord injury patients with bladder cancer. World J Urol 40, 1961–1970 (2022). https://doi.org/10.1007/s00345-022-03939-y
- Denervation of the urinary bladder
- Chronic neurogenic bladder dysfunction
- Chronic neurogenic bowl dysfunction
- Spina bifida
- Autonomic dysreflexia